Clinical Trials Directory

Trials / Completed

CompletedNCT01552499

Comparative Study of Amniotic Membrane Wound Graft In the Management of Diabetic Foot Ulcers

A Prospective, Randomized, Comparative Parallel Study of Amniotic Membrane Wound Graft In the Management of Diabetic Foot Ulcers

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
25 (actual)
Sponsor
MiMedx Group, Inc. · Industry
Sex
All
Age
18 Years
Healthy volunteers

Summary

The purpose of this study is to determine whether the EpiFix human amniotic membrane is effective in the treatment of diabetic foot ulcers.

Conditions

Interventions

TypeNameDescription
OTHERStandard of care
OTHERApplications of EpiFix

Timeline

Start date
2012-03-01
Primary completion
2012-08-01
Completion
2012-08-01
First posted
2012-03-13
Last updated
2015-08-17

Locations

1 site across 1 country: United States

Source: ClinicalTrials.gov record NCT01552499. Inclusion in this directory is not an endorsement.

Comparative Study of Amniotic Membrane Wound Graft In the Management of Diabetic Foot Ulcers (NCT01552499) · Clinical Trials Directory